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CHAPTER I 
INTRODUCTION 
Metabolic acidosis, a condition resulting in a reduction of 
plasma bicarbonate, was first described in 1831 by W. B. 
01 Shaughnessy, who noted that the alkali content was increased in 
the stool and decreased in the blood of patients with cholera. 1 
It was not until 1832, however, that the use of bicarbonate so-
lutions was first described by T. Latta, who administered the so-
lution intravenously to a dehydrated cholera patient. 2 
Bicarbonate gained popular usage after this success for 
treatment of acidosis, but fell into disfavor due to difficulties 
in sterilizing the solutions. 3 In 1932, Hartmann and Senn4 re-
ported the use of lactate as a bicarbonate precursor, while in 
1949, Mudge, Manning and Gilman5 recommended the use of acetate. 
However, unlike sodium bicarbonate, lactate and acetate require 
k b h 11 d b b l . 6-10 upta e y t e ce an su sequent meta o ism. 
If conditions exist in the animal, such as local tissue hy-
poxia, which might occur as a result of hemorrhage the metabo-
lism of these anions may be inhibited. 11 ,12 In 1962, Schwartz 
and Waters supported the use of bicarbonate, rather than lactate, 
to treat acidosis resulting from tissue hypoxia and hemorrhage. 13 
1 
Several studies have been conducted'comparing the efficacy 
of sodium bicarbonate and sodium lactate to result in alkalin-
ization.14,7,3,9,lo The conclusion drawn from these studies 
was that, while sodium bicarbonate is the best choice, sodium 
lactate can result in varying degrees of alkalinization, depend-
ing on dose, over a period of time. However, these studies were 
conducted in normovolemic animals or under anesthesia. 
It was the objective of this study to compare solutions con-
taining either sodium lactate or sodium bicarbonate as the alka-
linizing agent in a fluid replacement for a 20% blood loss in 
conscious dogs. 
2 
CHAPTER II 
LITERATURE REVIEW 
Water represents the most abundant component of the body and 
is the medium in which all life processes occur. 15 It is, there-
fore, necessary to maintain this fluid within relatively con-
stant limits, and this was first recognized by Claude Bernard in 
1850. 
Changes in the water and electrolyte content of body fluids 
may lead to disruption of normal cellular function and eventual 
death. This section will deal with normal fluid volume and com-
position and changes that can occur in volume and osmolality of 
the extracellular fluid (ecf) space. Subsequent sections will de-
tail the changes in cellular function that might occur as a re-
sult of fluid loss; the mechanisms of the body to maintain normal 
function and then principles governing fluid therapy. 
Body Water 
The total body water of an animal varies with the age, sex 
and fat content of the animal. 6,16 ,17 ,18 The percentage usually 
given for the total body water is 60~ of the body weight {Kg), 
with a range between 55% and 70%. 15 ,19 Total body water is dis-
tributed into two major compartments, the extracellular fluid 
3 
(ecf) and intracellular fluid (icf) spaces. Total body water and 
ecf can be measured in the living animal by the dye-dilution tech-
nique, utilizing isotopes, polysaccharides or ions. 15 ,20,21,16,22,23 
Representing approximately 20% of the body weight, the ecf 
compartment can be divided further into three compartments: 
plasma, interstitial fluid and transcellular. The blood plasma 
comprises about 5% of the body weight (7% of the body weight is 
usually considered blood volume) and can be measured by Evan's 
blue or cr51 or 1131 labelled red cells or serum albumin. 24-27 
Interstitial fluid volume, representing approximately 15% of the 
body weight, cannot be measured directly, therefore, it is mea-
sured by subtracting plasma volume from ecf volume. Intracellular 
fluid volume is also measured indirectly by subtracting ecf volume 
from total body water, and represents approximately 40% of the 
body weight. 
The chemical composition of plasma and interstitial fluid 
are similar in that sodium is the principal cation, and chloride 
and bicarbonate the principal anions. Potassium and magnesium are 
the primary intracellular cations, whereas the phosphates and pro-
teins are the principal anions. The major contributing factor to 
the difference between icf and ecf composition is the active 
transport of ions across the cell membrane. The major ion trans-
ported is sodium, which is actively moved out of the cells, while 
potassium is actively transported into cells. In most cases, 
anions are passively distributed. 
It is the active transport of sodium out of the cell that 
4 
regulates the volume of the icf space. Also, as a result of 
being the dominant osmotic element of the extracellular fluid, 
sodium and its associated anions are the regulators of ecf vol-
ume. The maintenance of this sodium-potassium distribution has 
important implications in the administration of fluids that con-
tain sodium and will be discussed in the section on fluid 
therapy. 
Disturbances of Volume and Osmolality 
Two terms, dehydration and overhydration, are co111T1on clini-
cal terms used to describe clinical disturbances. However, to be 
more accurate, disturbances should include some description of 
the volume and osmolality change. The index typically used for 
osmolality change is the sodium concentration. Based on volume 
and osmolality, several changes can take place (see Table I). 
The first is isotonic expansion. Isotonic expansion is the pro-
portional retention of sodium and water as occurs in edema or ex-
pansion of the ecf space with isotonic fluid. The fact that 
saline will remain essentially entirely in the ecf space remains 
an important consideration in fluid therapy. Hypertonic expan-
sion occurs when sodium accumulates in excess of water, as in 
adminsitration of hypertonic saline. Hypertonic expansion is the 
accumulation of water in excess of sodium, as in water intoxica-
tion. 
Contraction, or loss of fluid, from the ecf space can also 
be hypertonic, isotonic or hypotonic. Hypertonic contraction 
5 
Extracellular Change 
Isotonic Contraction 
Hypertonic Contraction 
Hypotonic Contraction 
Isotonic Expansion 
Hypertonic Expansion 
Hypotonic Expansion 
TABLE I 
TYPES OF CHANGES IN VOLUME AND OSMOLALITY 
Clinical Example 
Cholera 
Excess Sweating 
Renal Insufficiency 
Saline Infusion 
Hypertonic Saline 
Infusion 
Water Intoxication 
Volume Change Plasma 
ECW ICW Sodium 
0 0 
+ 
+ 
+ 0 0 
+ + 
+ + 
PCV Plasma 
Protein 
+ + 
0 + 
+ + 
0 
Direction of change is shown by symbols. 0 = no change; - =decrease;+= increase. ECW = extra-
cellular water; ICW = intracellular water; PCV = packed cell volume. (from Goodman and Gilman•s, 
The Pharmacological Basis of Therapeutics, pp. 848-884). 
is dehydration in which there is a loss of water in excess of 
sodium. Examples of this type of dehydration include diabetes 
insipidus, excessive sweating and osmotic diuresis. Hypotonic 
contraction occurs when there is a loss of sodium in excess of 
water. Adrenocortical insufficiency is a corrmon example of this 
type of dehydration. 
Isotonic contraction results from sodium and water loss in 
isotonic proportions. Disorders corrmonly found include loss of 
fluid from the GI tract (vomiting, diarrhea) or loss of blood as 
in hemorrhage. Assuming no other metabolic disorders, fluid re-
placement with saline, for example, would be the appropriate 
therapy. However, as in the case of hemorrhage, reflex changes 
in the cardiovascular system can lead to alterations in tissue 
perfusion. These changes in perfusion can eventually lead to 
metabolic abnormalities that require more than simple volume ex-
pansion correction. 
Hemorrhage and Cardiovascular Changes 
There are a number of models that have been used to study 
the effects of blood loss on body fluid shifts, cardiorespira-
tory changes and the subsequent effects of fluid replacement on 
these parameters. 28 In the Wigger's model, blood is withdrawn 
until an arbitrary blood pressure is reached. This pressure is 
maintained for a given time by periodic reinfusion or with-
drawal of blood from a heparinized reservoir. After a prede-
termined time at the reduced pressure, the blood is rapidly 
7 
11,28,29 
reinfused in the dog. It should be noted that this is a 
model of controlled hypotension and does not represent a natural 
model of hemorrhage. Any pressure adjustments by the animal are 
held in check by the investigator. 30,Jl Other models that have 
been used are repetitive removal of given blood volumes over a 
predetermined period; a single, massive hemorrhage of a percen-
tage of the blood volume or body weight; and total body exsangui-
nation.28,32 In these models, both splenectomized and/or nephrec-
tomized dogs were used and the majority of the experiments were 
done under anesthesia. 11 ,32 ,33 Despite the diversity of models, 
in 1965, Swan reported the status of a standardized experimental 
model designed to study the dynamic response of the animal to a 
single, massive hemorrhage. 34 The changes in the cardiovascular 
system following the loss of blood involve mechanisms designed 
to maintain perfusion to the heart, lungs and brain at the ex-
pense of flow to areas such as the gastrointestinal tract. The 
sympathetic nervous system, through the release of norepinephrine 
and epinephrine, result in vasoconstriction anQ a change in blood 
pressure. This sympathetic nervous system mediated vasoconstric-
tion is of great importance to the animal in the maintenance of 
blood pressure after hemorrhage.lG,ll, 35 In 1921, Meek and 
Eyster36 showed that morphinized dogs were able to compensate for 
blood loss averaging 2% of the body weight without significant 
changes in heart rate, arterial pressure and cardiac filling. 
It has also been demonstrated that a rapid loss of approximately 
50% of the blood volume is required to cause death in normal 
8 
animals. If the nerves of the reflex are sectioned, a rapid loss 
of only 10% of the blood volume proves fatal. 
Besides the reflex vasoconstriction, the shift of fluid 
from the interstitial space to the vascular system is another 
mechanism to maintain adequate tissue perfusion. 37 ,38 ,39 This 
process can account for restoration of approximately 80% of the 
fluid loss within hours. 28 ,32 This fluid shift and any new 
fluid entering the system (e.g., intravenous fluid administra-
tion) will dilute the plasma proteins. This protein will even-
tually be replaced and a nonnal concentration restored as a re-
sult of drainage from the lymphatic system. 37 
As previously mentioned, a consequence of the decreased tis-
sue perfusion is a change in cellular metabolism. 40 This change 
in cellular metabolism occurs in the three major energy processes 
of the cell: Glycolysis, the tricarboxylic acid (TCA) cycle, 
and gluconeogenesis. 41 -43 The pathways and its regulators will 
first be considered. 
TCA Cycle 
The TCA cycle, first postulated by H. A. Kregs in 1937, is 
a cyclic sequence of reactions that functions as the main path-
way for oxidation of carbohydrates. 44 The first step where ci-
trate is converted to tsocitrate can proceed anaerobically. It 
is the next step, conversion to alpha ketoglutarate, which is the 
first aerobic step. 44 ,45 Therefore, following a decrease in 
tissue perfusion, the development of a local tissue hypoxia will 
9 
inhibit the TCA cycle. 
Glycolysis 
Glycolysis is a catabolic pathway, breaking down glycogen 
or glucose to either lactic or ·pyruvic acids. 44 It is an anaer-
obic process and the most co1T111on fuel is glucose, although some 
organisms can use fatty acids. The overall balance equation for 
the process is: 
Glucose+ 2Pi + 2ADP~----->2 lactate+ 2ATP + 2H20 
where Pi is inorganic phosphate. There are two major stages of 
glycolysis, the first stage preparing glucose for catabolism by 
phosphorylation. It ends by cleaving the molecule into two, 
three carbon sugars. The second stage converts the three carbon 
sugars into lactate, via pyruvate. When pyruvate is formed, the 
redox state of the cell determines the subsequent reaction direc-
tion. The reoxidation of NADH by the transfer of H+ and its 
electron to oxygen through the respiratory chain is inhibited in 
an anaerobic state. 12 Under these conditions, pyruvate is re-
duced to lactate by lactate dehydrogenase (LOH). Tissues under 
anaerobic conditions, therefore, produce increased quantities of 
lactic acid, 12 ,44 and hence, a lactic acidosis develops. This 
increase in lactic acid due to hypoxia, has been show to occur 
by Huckabee95 even before any significant cardiovascular changes, 
such as a change in heart rate or blood pressure. 
Another factor responsible for the increased lactate is the 
10 
inhibition of the enzyme pyruvate dehydrogenase. 8 This enzyme 
is responsible for the conversion of pyruvate to acetyl CoA, a 
step necessary for glucose oxidation- via the TCA cycle. 44 
A major regulatory point in glycolysis is the phosphofruc-
tokinase (PFK) enzyme catalyzed reaction. This step is regulated 
by the concentration of ATP and ADP in the cell. 44 Increased 
[ATP] will inhibit this enzyme; high [ADP] will stimulate enzyme 
activity. However, the decrease in intracellular pH, which 
occurs during anaerobiosis, will inhibit PFK activity despite 
the higher concentrations of ADP seen during hypoxia.a, 45 ,43 
Gluconeogenesis 
An important response to the energy and substrate deficits 
of inadequate tissue perfusion is the stimulation of gluconeo-
genesis.44 Since glucose is the only substrate that supplies 
energy to the cell under anaerobic conditions, alternative fuel 
sources must be converted to glucose. The metabolism of lactate, 
the major product of anaerobic metabolism, will now be discussed 
in its relation to gluconeogenesis. 
Lactate is converted to pyruvate in a reac~ion catalyzed by 
LDH, which is a reversal of the reduction of pyruvate to lac-
tate.45 There are two isozymes of LDH, each with its own affini-
ty for pyruvate. Those tissues with a high enzyme affinity for 
pyruvate do not easily convert lactate into pyruvate. In these 
tissues (e.g., skeletal muscle), the LDH reaction has a greater 
tendency to proceed from pyruvate to lactate. 44 ,45 However, in 
11 
in conditions of high ecf lactate concentration, skeletal muscle 
can utilize lactate as an oxidative substrate. In other tissues 
theart, liver), the reaction will proceed favorably in the direc-
tion of pyruvate. 44 
The next few steps involve the conversion of pyruvate to 
phosphoenolpyruvate {PEP) via oxaloacetate. The enzymes involved 
are pyruvate carboxylase and PEP carboxykinase. The same enzymes 
of glycolysis are followed in reverse order, until the formation 
of fructose 1,6-diphosphate. At this point, the enzyme fructose 
1,6-diphosphatase removes a phosphate group to form fructose 
6-phosphate. 
Gluconeogenesis is inhibited by a decrease in intracellular 
pH, at the pyruvate carboxylase and PEP carboxykinase steps. A 
low energy state {increased [ADP]) inhibits the enzyme fructose 
diphosphatase. 45-49 
In summary, the reduced tissue perfusion resulting from hem-
orrhage, leads to specific metabolic changes. Under anaerobic 
conditions, glycolysis becomes the primary source of energy, re-
sulting in the production of large amounts of lactic acid. Inhi-
' 
bition of gluconeogenesis and the TCA cycle by the decrease in 
intracellular pH, results in underutilization of lactate, leading 
to a clinical acidosis. 50-52 
The clinical manifestations of blood loss can be followed 
in changes in blood gases, plasma potassium levels and the anion 
gap (the difference between the concentrations of the cations, 
sodium and potassium, and the anions, chloride and bicarbonate):3 
12 
The titration of organic acids in e·xtracellular fluid leads 
to a decrease in bicarbonate concentrations and pH. To maintain 
the pH within limits compatible with life, there are three mecha-
nisms, each varying with the rapidity of the response. The first 
is a chemical buffering that reacts immediately with added acid 
or base. 15 ,16 ,21 The second mechanism is the respiratory system 
which regulates the carbon dioxide levels (PC02) of body fluids~ 8 
The final mechanism, the renal mechanism, is a relatively slow 
process which regulates both hydrogen ion and bicarbonate con-
centrations of extracellular fluids. 21 
Buffers 
A buffer system is a solution containing a weak acid along 
with its conjugate base, which functions to resist changes in pH 
when a stronger acid or a base is added. 54-56 A typical reaction 
of buffer action can be understood in terms of the following equa-
tion: 
HCl + CH3COO-Na+ <----;::> NaCl + CHfOOH 
acid conjugate 
base 
SaH weak acid 
This equation states that the conjugate base of acetic acid 
(sodium acetate) binds the hydrogen ions dissociated from the 
strong acid, to form a weak acid and a neutral salt. 57 There is, 
however, a definite limit to how much acid or base can be added 
to a buffer solution before an appreciable change in pH will re-
sult. This limit is known as the buffer capacity and is set by 
i3 
the original quantities of the weak acid·and its conjugate base, 
since one or the other is consumed in any buffer reaction. 4 
Buffer Value and Efficiency 
In 1914, Max Koppel and K. Spiro introduced the concept of 
the buffer value of weak acids and bases, 78 although it was much 
later that Van Slyke added a physiologic mechanism as an impor-
tant perspective to the buffer studies. 78 
The efficiency of a buffer is determined by the relationship 
of the pKa and pH of the solution. 16 A buffer is most efficient 
at its pKa ± 1 pH unit. 55 The addition of acid or base when the 
buffer is within this range results in a smaller change than at 
other pH values. The efficiency is greater at this point because: 
1) the concentration of the acid and base are equal; and 2) the 
equilibrium does not favor a reaction in either direction. 52 
Table II lists various blood buffer pairs, the pKa and the base/ 
acid ratios at several physiologic pH values. It can be seen 
that even at a pH of 7.0 the lactate/lactic acid ratio is 1258/1. 
For sodium lactate to act as a base, the reaction 
Socium lactate +HA <-->Lactic acid + A-
where A- is the conjugate base of HA, must take place. However, 
at pH 7.0, only l/1258th of the sodium lactate present would be 
capable of this reaction. An important concept relating to buf-
fering efficiency is the relationship between the pKa and the 
affinity of the conjugate base for protons. The general rule is, 
the lower the pKa, the stronger the acid and the weaker the base. 
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TABLE II 
BLOOD BUFFERS AND ACID/BASE RATIOS AT 
SEVERAL PHYSIOLOGIC pH VALUES 
Buffer Ratios at pH Values: 
Pair pKa 7.0 7.4 
ammonia/ammonium 9.37 .004 .01 
HP04/H2P04 6.8 1. 5 4 
HC03- /H2C03 6.1 7.9 20 
8-hydroxybutyrate/ 
8-hydroxybutyri c 4.8 158 398 
propionate/propionic 4.8 158 398 
acetate/acetic 4.5 316 798 
lactate/lactic 3.9 1258 3100 
acetoacetate/ 
acetoacetic 3.8 1584 3980 
7.6 
.02 
6.3 
32 
630 
630 
1258 
5000 
6300 
The values presented are the base/acid ratios at the listed pH values. 
The denominator in all cases is 1 (eg. ,.004/1). 
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When comparing acetic acid and the lacti"c acid with pKa's of 4.5 and 
3.9 respectively, this rule would predict that lactic acid, be-
ing a stronger acid than acetic, the conjugate base sodium ace-
tate has a greater proton affinity than sodium lactate. If a 
proton transfer reaction was to occur between sodium lactate and 
acetic acid, the following reaction would take place: 
acetic acid+ sodium lactate acetate+ lactate acid 
A general form of the two preceding reactions might be stated as 
follows using the symbols: AH, representing the stronger acid, 
and BH, representing the weaker acid; A-, B- as the conjugate 
gases of the corresponding acids. In the reaction 
if the pKa of AH is greater than the pKa of BH, the general con-
cept is that an acid cannot be effectively buffered by the salt 
of a stronger acid (or one with a lower pK value). 
A second important consideration is the ability of animal to 
alter the base/acid ratio by physiologic mechanisms. 15 ,18 This 
is an important mechanism in the bicarbonate - carbonic acid sys-
tern. Referring to Table II, it would appear by virtue of the pKa, 
the phosphate system would be most efficient of the physiologic 
buffers, for buffering at pH 7.4. However, since the bicarbonate 
- carbonic acid system is easily and rapidly regulated by respira-
tory alterations of the levels of carbon dioxide in the blood 
(pC02, measured in mmHg), this buffer system is very efficient 
for buffering at pH 7.4 in extracellular fluid. 19 
16 
Another way of expressing the efficiency of a buffer is by 
its buffer value. The buffer value of a solution at any pH is 
defined as the negative slope of titration curve at that pH. 19 
The slope is the amount of acid or base that is needed to pro-
duce a pH change of l unit. 55 The steeper the curve, the 
greater the amount of acid needed to change the pH. The buffer 
value is usually expressed as mmols per liter per pH unit. For 
any weak acid or base, this value is 0.575 per pH unit for each 
ionizing group on the molecule, regardless of its structure or 
Ka. 58 For substances with multiple ionizing groups, such as 
the proteins, hemoglobin and the polyprotic acids, the pH range 
of operation is an important consideration. 19 This will be dis-
cussed below in a consideration of the hemoglobin - plasma pro-
tein buffers. 
Body Buffers 
There are a number of buffer systems within both the extra-
cellular and intracellular fluids. 15 ,21 The intracellular buf-
fers are the various phosphates, organic anions such as pro-
teins, the bicarbonate-carbonic acid system and hemoglobin. 18 
Since intracellular fluid is approximately 67% of total body 
water, these buffers represent a considerable quantity of buffer 
chemicals and they play an important role in the maintenance of 
the pH of body fluids. 
Extracellular buffers include plasma proteins, and the weak 
17 
Na2HP04, sodium acetate/acetic acid and sodium lactate/lactic 
acid. 21 
Bicarbonate/Carbonic Acid System 
The discovery of the critical role of the bicarbonate/car-
bonic acid buffer system paved the way for the elucidation of 
acid base physiology and an appreciation of the clinical distur-
bances of acid base metabolism. 52 The most important discovery 
in the acid base field was made by L. J. Henderson in 1908. 52 
From observations made in the previous century and his own obser-
vations on the bicarbonate and phosphate buffers, he recognized 
that the bicarbonate/carbonic acid buffer plays a central role in 
stabilizing the acid base status of the animal. 79 He pointed out 
that the response of this system to the introduction of acid in-
valves a rapid reduction in carbonic acid, achieved by removal of 
carbon dioxide by the lungs. 
co2 (gas) 
C02 (dissolved)+ H2°<-->H2CD3 H+ + HC0-3 
This is an important feature of this buffer system and is a reason 
why this system is efficient despite a pKa of 6.1. 15 •19 
The pH of this system can be determined by the Henderson-
Hasselbalch equation: 
{ H2co3 } pH = pKa + log H CO or since { H2co3 } = .031 x PC02 { 2 3} 
{ H2co3 } 
= pKa + log .031 x PC02 
18 
If a closed system is present, where the·concentration of acid 
increases as H+ reacts with the base, addition of 10 mEq of acid 
will lower the pH from 7.4 to 6.2. 1 However, in an open system, 
where excess carbon dioxide is allowed to escape while PC02 re-
mains constant, the pH changes ·from 7.4 to 7.2. The constant 
PC02, in vivo, is maintained by production of co2 by the cells, 
and the regulation of respiratory ventilation by pH of extracel-
lular fluids. 19 The buffer value, at a constant PC02 can thus 
be calculated and is found to be 2.3 per pH unit,a vilue four 
times that of ordinary buffers. 19 
In this open system, unlike other buffer systems, diluting 
the system will change the buffering ability and pH. Adding water 
is equivalent to adding acid (dilutional acidosis) and removing 
water is equivalent to adding base (concentration alkalosis). 15 
Thus, changes in body water volume can have acid base effects. 
Hemoglobin and Plasma Proteins 
Figure 1 is a diagram of the role of hemoglobin and ery-
throcyte in buffering the carbon dioxide released from tissues. 
In this example, carbon dioxide rapidly diffuses into the ery-
throcyte. A fraction remains dissolved while the majority com-
bines with water and through a reaction catalyzed by carbonic 
anhydrase, carbonic acid is formed. Carbonic acid dissociates 
into the bicarbonate and hydrogen ions. The bicarbonate ion 
leaves the cell in exchange for chloride, while the hydrogen ion 
is buffered by hemoglobin. 15 ,59 Titration of 1 mmol per liter 
19 
TISSUE 
MEMBRANE 
PLASMA ERYTHROCYTE 
C02]+ H20 
C.A. 
H~ 
HC03- + H+\ 
c1--fc1-I Hemoglobin-H+ 
i 
i 
lMEMBRANE 
Figure 1. The Buffering of Carbon Dioxide by Hemoglobin 
C.A. = Carbonic Anhydrase 
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solution of oxhemoglobin and hemoglobin,' over the pH range 7.0 
to 7.8 (Figure 2) gives a buffer value (or slope) of 3.0 per unit 
change pH. 19 ,60 The buffer value of hemoglobin in a liter of 
blood is 22.7. 19 
The buffer value of whole.blood can be found by the addition 
of the buffer values for hemoglobin and plasma proteins. As with 
hemoglobin, the buffer value of the plasma proteins is dependent 
upon the concentration of plasma protein. According to Van 
Slyke et al, 58 the buffer value of protein, which is measured in 
mmol/gram/unit pH is 0.1. Assuming a normal protein concentra-
tion of 7 grams per 100 ml and a hematocrit of 45, one liter of 
plasma has a buffer value of 3.9. Adding this to 22.7 (buffer 
value of hemoglobin) gives 26.6 as the buffer value of whole 
blood. 19 
These experiments are a reflection of the buffering capabil-
ity of extracellular fluid as a whole. Since interstitial fluid 
is essentially protein free, the buffering of carbonic acid in 
extracellular fluid is primarily the responsibility of plasma pro-
teins and hemoglobin. Titrations of whole blood with a noncar-
bonic acid will involve all the buffer systems, including the bi-
carbonate/carbonic acid system. 19 
The change in buffer value of true plasma removed from ery-
throcytes prior to changes in pC02 or before any significant re-
action with hemoglobin versus separated plasma allowed to equili-
brate with carbon dioxide and hemoglobin (of the erythrocytes), 
has an important implication in acid base disorders. As mentioned 
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Figure 2. Titration of Hemoglobin (HB) and Oxyhemoglobin (HB02) 
(From: Woodbury, D.M. Physiology of Body Fluids. In: 
Ruch and Patton, Physiology and Biophysics II Circulation, 
Respiration and Fluid Balance, 1974, pp. 450-479). 
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previously, addition of acid to the system will result in a 
movement of bicarbonate ions out of the erythrocyte, which will 
increase the availability of base outside of the cell. This 
movement will also tend to dampen any change in extracellular 
sodium bicarbonate due to consumption by the acid. The implica-
tions in acid base disorders is that, by virtue of this dampen-
ing process, a mild increase of acid may not result in a change 
in the extracellular bicarbonate concentration, but does result 
in a reduction of intracellular HC03-. More important is the 
idea that when changes in extracellular fluid bicarbonate concen-
trations are noted, as by a decrease in the base excess, the in-
tracellular reserves are already partially depleted. This will 
be discussed further in the fluid therapy section. The role of 
other intracellular buffers will be discussed below. 
In discussing the buffering of metabolic acidosis, the ori-
gin of the acid needs to be considered. In the classic study by 
Swan and Pitts,61 the infused acid was hydrochloric acid. It 
has been shown, however, that the response to organic acid infu-
sion is slightly different from that to a mineral acid. 14 
If a strong mineral acid such as hydrochloric acid is in-
fused, approximately one percent is buffered by the extracellular 
fluid proteins. The hydrogen ions are accepted by the proteins, 
displacing cations, primarily sodium, resulting in an increased 
sodium chloride concentration. Approximately six percent of the 
buffering results from an exchange of extracellular chloride for 
intracellular bicarbonate involving the erythrocytes. Forty-three 
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Intracellular Fluid Extracellular Fluid 
Na+ H+ 36~ 
K+ H+ 15% 
HC03 Cl- 6% 
total intracellular buffering 57% 
42% 
Protein + H+ l~ 
total extracellular buffering 
Figure 3. Meehan ism of Buffering in Metabo 1 i c 
Acidosis. This figure represents the 
mechanism of buffering after infusion 
of a strong mineral acid (HCl). The 
intracellular buffers account for the 
majority of buffering (57<); whereas 
the extracellular beffers account for 
approximately 43% of the buffering. 
(From: Swan, R.C., Pitts, R.F. 
Neutralization of infused acid by 
nephrectomized dogs. J. Clin. 
Invest. 34:205-212, 1955) 
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percent of extracellular buffering occurs with the sodium bi-
carbonate system, resulting in an increased PC02. The greatest 
fraction of acid is buffered by the exchange of cellular potas-
sium (15%) and sodium (37%) for extracellular hydrogen ions. 21 ,61 
The changes occurring after infusion of an organic acid, 
such as lactic acid, are somewhat different than those described 
above for HCl infusion. 14 During infusion of lactic acid, al-
though the concentration does initially rise, it rapidly falls 
after the infusion is discontinued. This rapid disappearance is 
attributed to its free diffusibility within total body water and 
to cellular metabolism. It has been shown that within ten 
minutes of injection, 40% of the lactic acid dose is metabo-
lized. The buffering by extracellular bicarbonate only accounts 
for approximately 33% of lactic acid disappearance. These ex-
periments were performed in normal animals with no evidence of 
tissue hypoxia. Under anaerobic conditions, however, the metab-
olism of lactate is blocked by enzyme inhibition due to pH 
changes. 
Renal Regulation of Acid Base Balance 
The discussion so far has focused on the chemical compensa-
tion of acidosis or alkalosis. Respiration is the second line of 
compensation because changing the respiratory rate wi 11 alter the 
PC02.15 This, in turn, will alter the bicarbonate-carbonic acid 
ratio and thus the pH. (See previous discussion of the bicarbo-
nate buffer system for more detail.) 21 ,19 
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The third mechanism of acid base regulation is the renal 
mechanism, which occurs over a long period of time. The renal 
response can be divided into separate phases, as follows: 
1) the reabsorption of sodium bicarbonate; (2) the excretion of 
titratable acids; and 3) the excretion of anions in combination 
with NH4+ instead of Na+. 20 
Potassium 
Associated with changes in blood acidity are changes in the 
plasma [K+]. It is widely accepted that acidosis is associated 
with K+ release from the cells with an increase in plasma [KJ. 62 
There have also been attempts to quantitate the changes in plasma 
Kasa function of pH.· According to Scribner et a1 65 and 
others63 ,64 a change in pH of .l unit leads to a change of 0.6 
mEq/1 of plasma potassium in the opposite direction. This value 
was derived through the study of mineral acid induced acidosis. 
Recent studies using organic acids indicate that this gene-
ralization may not be applicable to clinical acidosis. In fact, 
it appears that differences exist among the acid base disorders 
with respect to changes in plasma potassium concentration. 66-70 
These changes appear to depend on factors other than pH, such as 
plasma osmolality, adrenergic activity, insulin levels, liver 
activity and plasma bicarbonate concentration. 63 ,71 ,72 ,73 The 
discussion will focus on the changes occurring during metabolic 
acidosis. 
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Metabolic Acidosis 
The acidosis as a result of infusion of a mineral acid, 
such as hydrochloric or ammonium chloride, consistently leads to 
an increase in plasma potassium. In sharp contrast, acidosis 
as a result of organic acid (lactic acid, acetic acid, b-OH Bu-
tyric and methylmalonic_ acids) infusion was not associated with 
a significant change in plasma potassium concentration. 63 •73 •74 
Anion Gap 
In addition to serum electrolyte and blood gas determina-
tions, calculation of the anion gap is becoming a useful clini-
cal tool. 75 •76 The anion gap is the difference in the sum of the 
routinely measured cations (sodium, potassium) and the sum of the 
routinely measured anions (chloride, bicarbonate): 52 •53 
anion gap= ([Na]= [K]) - ([Cl]+ [HC03]) 
On the basis of the normal values of the ions, in mEq/1, the dif-
ference between the concentrations of cations and anions ranges 
from 10 to 16 mEq/1. 
anion gap= {[Na]= =[K]) - ([Cl]= [HC03]) 
= (145 + 5) (110 + 25) 
= 150 - 135 = 5 mEq/liter 
The difference of 15 mEq/1 reflects a concentration of cations 
in addition to Cl and HC03- which are unmeasured in routine ex-
amination of plasma. The concentration of unmeasured anions 
{phosphate, sulfate, organic acids, proteins) generally exceeds 
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that of the unmeasured cations (magnesium, calcium). 
An increased or decreased anion gap may result from a change 
in the unmeasured anions or a change in the measured cations. 
The primary usefulness of the anion gap lies in its delinea-
tion of the various causes of metabolic acidosis. 75 An increased 
anion gap occurs in metabolic acidosis produced by diabetic ke-
toacidosis and lactic acidosis. In the former condition, pro-
duction of acetoacetic and B-hydroxybutyric acids exceed their 
rates of metabolism and excretion. Lactic acidosis tissue hypox-
ia which decreases aerobic oxidation of glucose in the tricarbox-
ylic acid cycle will lead to increased lactic acid levels of 
plasma. This increased liberation of lactic acid, which exceeds 
its rate of conversion by the liver to glucose, leads to the in-
creased anion gap. Acute renal failure may also be associated 
with an increased anion gap. 75 ,76 ,77 
Conditions associated with a normal or decreased anion gap 
in metabolic acidosis are renal and gastro-intestinal loss of 
bicarbonate, hyperchloremic acidosis and dilutional acidosis. 
In the decrease of the anion gap during acidosis, it has been 
demonstrated by Androgue et a1 75 that approximately 40% of the 
observed decrease in the gap is due to plasma proteins. Ashy-
drogen ions are added to plasma, the negative charge on the pro-
teins will decrease, resulting in a decrease of the anion gap. 75 
In summary, the changes that occur as a result of a metabo-
lie acidosis are: a decrease in plasma bicarbonate, an increase 
in the negative base excess; an increase in the anion gap 
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(>20 mEq/1) and plasma potassium; and a aecrease in PC02 due to 
respiratory compensation. 
To this point, the discussion has focused upon the changes 
that occur as result of hemorrhage and the mechanisms of the 
body designed to minimize the changes in acid base status. The 
discussion will now turn to fluid therapy and the basis of treat-
ment of the metabolic disorders that result from hemorrhage. 
Fluid Therapy 
The aim of fluid therapy, in cases where there is a de-
creased circulating blood volume, is the re-establishment of ade-
quate tissue perfusion to prevent cell death. 80 Associated with 
this is the correction of the acid base status of the animal. 
There are a number of commercially available solutions for 
body fluid volume restoration ranging from those containing only 
sodium chloride (normal or physiologic saline) to polyionic solu-
tions (Ringer's and lactated Ringer's solutions) to dextrose in 
water. 17 In choosing a solution for administration, the nature 
of the deficit in either volume and/or electrolytes is usually 
considered. 
As previously mentioned, loss of blood will result in reflex 
cardiovascular changes designed to maintain perfusion of the 
heart, brain and lungs at the expense of the cutaneous and 
splanchnic circulations. This decrease in perfusion in these 
areas will result in local tissue hypoxia and lead to the devel-
opment of metabolic acidosis. 
29 
The buffer systems of the body will·, in part, compensate 
for the acidosis, 15 ,19 and shifts will tend to compensate for 
the blood loss. 39 To assure adequate perfusion, however, fluid 
replacement may be a necessary step. 17 The best replacement for 
the blood loss would be whole blood. 81 If this is not available, 
then plasma should be considered, followed by plasma expanders, 
such as dextran. If none of these are available, balanced elec-
trolyte solutions are the. next choice. 82 There are a number of 
these available, but the discussion will focus on the following 
commonly used solutions: normal or physiologic saline, lactated 
Ringer's and 5% dextrose in water (D5W). 
Physiologic or normal saline is a 0.9% solution of sodium 
chloride (150 mEq/1 each ion). In terms of expanding the ecf 
space, it is efficient. Its first reported successful use in the 
treatment of fluid loss was in 1891. 83 However, a problem asso-
ciated with the use of saline is the dilution of the bicarbonate 
buffer system, leading to a dilutional acidosis. 84-87 The acidi-
fying effect of saline has been debated for many years,84 ,85 
first being proposed by Peters and Van Slyke in 193188 and demon-
strated by Shires and Holman in 1947. 87 Although it is now es-
tablished that saline infusion can result in an acidosis,84 ,89 
there is still disagreement as to the amount necessary to result 
in a significant lowering of the plasma bicarbonate. 86 ,87 
Garella et al, 86 state that the ecf space needs expansion by 
approximately 40% over its original volume in normal animals to 
result in a significant acidosis. It has been suggested by 
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Garella et a1 87 and others90 that the minor changes in pH and 
bicarbonate that occur following saline infusion are a result of 
intracellular buffering. It should be noted, however, that these 
investigations were carried out in normovolemic animals with no 
apparent acid base disturbances. The use of normal saline would 
appear to be contraindicated for use in animals with a metabolic 
acidosis, whose buffering systems are already being challenged 
by the accumulation of organic acids. 41 The use of a buffer 
base with the saline, such as bicarbonate, would be a logical al-
ternative. This will be discussed in further detail below. 
In the case of D5W, a similar condition of dilutional aci-
dosis occurs. However, the degree of dilution is less severe 
due to entry of the glucose and water into the cell. 17 The glu-
cose solution partitions itsel,f according to the icf/ecf water 
volumes, with 2/3 of the added solution entering the cells: 1/3 
remaining in the ecf space. Because glucose distributes to the 
total body water pool it has less value as a blood loss replace-
ment than does saline. Glucose solutions dilute both icf and 
ecf. Dilutional acidosis of both compartments result, whereas, 
in saline infusion, only ecf dilution results; 
Lactated Ringer's solution is an isotonic, polyionic solu-
tion introduced in 1932 by Hartmann and Senn. 4 It is now widely 
used as a therapy for several reasons. The first is that the 
sodium lactate is assumed to act as a buffer in cases of acidosis. 
This point will be discussed below. Based on this buffer base 
concept, Ringer's solution would only theoretically result in a 
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temporary dilution of plasma bicarbonate, thus avoiding dilution-
al acidosis. The final reason is that it provides electrolytes, 
namely K+ which may be lost during acidosis. However, during 
acidosis, there is a rise in plasma potassium, and increasing 
plasma Kin the presence of an unknown renal function may lead 
to complications, such as cardiac arrhythmias. 
As mentioned previously, even in cases where there are no 
metabolic disorders, the use of a buffer base such as sodium bi-
carbonate in fluid replacement therapy is important to prevent 
a dilutional acidosis. In these cases, the base requirement to 
prevent dilution of the plasma bicarbonate would be the normal 
concentration of bicarbonate, or 25 mEq/1. 17 Because the appar-
ent HC03- space is approximately equal to 83% of total body 
water, the use of 25 mEq/1 of fluid is required for either saline 
or glucose to prevent dilutional acidosis. 
If, however, there are signs of acidosis, the base require-
ments will change. One consideration is the type of alkali to 
use in the correction of the acidosis. 9,91 There are several pos-
sible alkalinizing agents, namely the sodium salts of the follow-
ing weak acids: lactic, carbonic, acetic, succinic and glu-
conic.92,93,9l,l0,9 Of these compounds, sodium bicarbonate is 
indicated for acute severe metabolic acidosis, because of its 
rapid effect when given intravenously. 9 
This is based first of all, on the physical chemical proper-
ties of the bicarbonate-carbonic acid buffer system. Having a 
pKa of 6.1, this system would be most effective within the normal 
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pH range of most organisms, and would therefore accept hydrogen 
ions from essentially all metabolic acids. (Note: Recall it is 
the ease with which the concentrations of carbonic acid can be 
changed via respiration that allows bicarbonate to be effective 
against phosphate, pKa 6.8.) On the other hand, the pKa of the 
lactate/lactic acid system is 3.9. Therefore, at a pH of 7.4, 
almost 100% of the lactic acid would exist as sodium lactate. 
This prevents it from accepting hydrogen ions and thus act as a 
buffer. 
A second reason why sodium bicarbonate is considered a more 
effective alkalinizing agent is that it does not require metabo-
lism to work. 9,lo, 9l According to these investigations and 
7 41 82 93 94 . . 
other' ' ' ' agents such as sodium lactate are effective as 
buffers only after metabolism to sodium bicarbonate. It is the 
generated sodium bicarbonate which is the effective buffer agent. 
Both Hartsfield9,lo and Kirkendo1 93 have shown an increase in 
sodium bicarbonate following infusions of sodium acetate or sodi-
um lactate, which is consistent with this idea. In the study by 
Kirkendol et a1 93 sodium acetate increased plasma bicarbonate 
after 20 minutes of infusion, while sodium lactate increased plas-
ma bicarbonate after 40 minutes of infusion. 
However, if lactate or acetate is metabolized the products 
formed are carbon dioxide and water and not sodium bicarbonate! 4,44 
This was demonstrated by Mithoefer and Karetzky14 who infused 
lactic acid in anesthetized dogs and found an increase only in 
the PC02. The PC02 values were also found to increase in the 
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Hartsfield9,lo study, which would indicate that lactate or ace-
tate were metabolized to co2. (NOTE: All experiments were car-
ried out in normovolemic animals.) 
A possible source of the rise in bicarbonate seen in the 
Hartsfield study or Kirkendol i-nvestigation9,lo,93 could be ion 
exchange. As the lactate (or acetate) ion would enter the cell, 
an intracellular anion would need to leave the cell to maintain 
electroneutrality. The anions that could take part in this ex-
change would be either chloride or bicarbonate. 
A final reason for choosing sodium bicarbonate as an alkaline 
buffer fluid therapy in metabolic acidosis is that the acidosis 
resulting from blood loss and/or tissue hypoxia is a lactic 
acidosis. 41 ,95 This type of acidosis, resulting from volume de-
pletion, was described by Clausen in 192597 and by Hartmann and 
Senn4 in 1932. Huckabee95 and Phillipson et a1 96 also described 
lactic acidosis resulting from a decreased tissue perfusion. The 
mechanism of the increase in plasma lactate concentrations re-
results from overproduction and underutilization of lactate. The 
administration of a solution that contains lactate as a buffer 
system is ineffective in buffering its own acid or base. 
The proponents of lactate therapy state, however, that, al-
though there is a metabolic consideration, increasing tissue 
perfusion, which will, in itself, correct any metabolic abnor-
malities, also adds an additional di1utiona1 acidosis to compli-
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cate therapy. Canizaro et a1 99 have stated that adding lactate solu-
tion to an already overloaded system does not have a significant 
effect and is probably not detrimental to the animal. In a series 
of 23 unconscious dogs, bled 60% of their calculated blood volume, 
mean blood lactate increased from a control level of 13 mg% to 91 
mg% within 30 minutes following bleeding. When treated with lac-
tated Ringer's the blood lactate concentrations increased slight-
99 ly to 100 MG%. Blood gas or pH measurements were not available 
but based on blood lactate levels, the treatment would seem to be 
hindering the objective of decreasing blood lactate levels. 
Once the clinician has decided on the buffer base to use, the 
next question to answer is the quantity of base to add.loo (Sodium 
bicarbonate is the example which will be used in this discussion.) 
The severity of the metabolic acidosis is usually estimated 
by determination of the base excess. 84 The base excess is usual-
ly calculated from the plasma concentration of bicarbonate and 
pH. 52 It should be realized that the base excess only represents 
the sodium bicarbonate excess, with a positive excess associated 
with alkalosis; a negative excess with acidosis. 57 ,44 The amount 
of bicarbonate to be administered, in mEq/1, is usually calcu-
lated from the formula of Mellemgard and Astrup.lOl This formula 
estimates the bicarbonate replacement in a nonrespiratory acido-
sis to be 0.3 x body weight (kg) x base excess. The term 0.3 x 
body weight {kg) somewhat overestimates the ecf space.l?,lOO 
This formula may prove inadequate for two reasons. 100 The first 
is that it does not include the 25 mEq/1 maintenance dose or nor-
mal concentration of bicarbonate needed to prevent dilutional 
acidosis. The other reason is that the base excess does not 
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account for buffering by the other buffering systems of the body 
{e.g. ,intracellular buffers account for 57% of the buffering in 
a mineral acidosis) and the dampening of bicarbonate loss by 
hemoglobin. 61 Depending on the severity and longevity of the 
acidosis, the bicarbonate concentration may fail to rise when 
corrected in this manner. 100 It has been demonstrated by 
Garella et allOO that bicarbonate will distribute itself in a 
apparent fluid space equal to 50% of the body weight, and in 
some cases the requirements may theoretically exceed 100% of the 
body weight due to the need to restore other buffer systems. 
Objective 
Based on the pKa values for sodium lactate and bicarbonate, 
it is hypothesized that sodium bicarbonate would act as a more 
efficient proton acceptor for use in fluid replacement to car-
rect a metabolic acidosis produced by a 20% blood loss. 
The acid base status will be monitored by changes in blood 
gases, specifically a decrease in plasma bicarbonate, or an in-
crease in the negative base excess. Other changes that could oc-
cur in the blood gas status of the animal would be a decrease in 
pH and/or PC02; the decrease in the latter index is a result of 
respiratory compensation. Subsequent analysis of the anion 
gap will be used to confirm the presence of an acidosis 
{>20 mEq/1). To remove any influence of anesthesia on compensa-
tion mechanisms or on the acid base status of the animal, these 
experiments will be conducted on conscious animals. 
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CHAPTER III 
MATERIALS - METHODS 
Ten mongrel dogs, of either sex (4 males, 6 females) and 
varying body weights {average 16 ± 2 S.E. kilograms) were ob-
tained from the Oklahoma State University animal care unit. 
Upon arrival, and once per day for three consecutive days, di-
rect blood smear examinations for heartworms, complete blood 
counts and serum electrolytes were determined for each animal. 
A lead II electrocardiogram was obtained to screen for any car-
diac abnormalities. 
Each dog was vaccinated for canine distemper and rabies at 
the time of arrival. All dogs were housed singly in runs and 
fed standard laboratory chow and water ad libitum. 
Preparation of Animals 
One week prior to experimentation, each dog was anesthe-
tized with thiopental sodiuma (3mg/kg) and methoxyflurane.b The 
left carotid artery and left jugular vein were cannulated with a 
combination polyethylenec/Silastic tubingd cathether. The cathe-
ters were filled with heparinized salinee, sutured in place, and 
externally secured with gauze bandaging and Elastikon. The dogs 
were allowed free access to food and water. Following surgery, 
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catheters were flushed daily with 1000 U sodium heparin in 1 ml 
sterile saline.f 
Two days prior to experimentation, body fluid volumes were 
determined using antipyrineg for total body (20 mg/kg); potas-
sium thiocyanateh for total extracellular fluid (15 mg/kg); and 
Evan's bluei for plasma and blood volume (0.4 mg/kg). At each 
sampling interval, the indices which were to be measured during 
the experiment were also determined. These indices were: serum 
sodium, potassium chloride; arterial pH, PC02, P02, HC03-,baseex-
cess; red blood cell count, hemoglobin concentration, packed 
cell volume, total plasma protein and anion gap. The sampling 
intervals were at time O (pre-dye injection), +10,20,30 and 90 
minutes. 
Experimental Procedure 
The basic experimental plan consisted of bleeding each ani-
mal 20% of their measured blood volume over a 15-30 minute inter-
val, following a 20 minute stabilization period. Blood samples 
were drawn at intervals, for the above indices, and invnediate 
blood gas analysis, until acidosis was established. Criteria 
for an acidotic state was a base excess of~ -4 mmol/1. After 
the establishment of a metabolic acidosis, one of five treat-
ments was initiated. 
Table III is a list of treatments used in this experiment. 
The blood sampling intervals were at time O (immediately after 
cessation of treatment), +10, 20, 20, 90, 150, 210 and 1440 
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TREATMENT# 
1 
2 
3 
4 
5 
TABLE II I 
LIST OF TREATMENTS 
Control Group - no fluid replacement 
Fluid Replacement with: 
100 mEq/ l Na Cl 
25 mEq/1 sodium lactate 
25 mEq/1 sodium gluconate 
Fluid Replacement with: 
100 mEq/1 Na Cl 
25 mEq/1 sodium· lactate + correction 
25 mEq/1 sodium gluconate - correction 
Fluid Replacement with: 
100 mEq/1 NaCl 
25 mEq/1 NaHC03 
25 mEq/1 sodium gluconate 
Fluid Replacement with: 
100 mEq/1 NaCl 
25 mEq/1 NaHC03 + correction 
25 mEq/1 sodium gluconate - correction 
Fluid volume replaced was equal to 20% of the measured blood volume. 
The correction was the quantity, in mEq/1, that was equal to 0.3 x 
Body Wt (Kg} x Base Excess. 
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minutes. The dye indicators for determination of body water 
distribution were injected after the zero time sample. Each 
dog went through two experimental trials separated by a one week 
interval, and each treatment was assigned four dogs. 
Sample Analysis 
Arterial blood gases and pH were measured on a Corning 175 
automatic pH/blood gas system. Serum sodium and potassium were 
measured with a Beckman Klina FlameR; serum Chloride with a 
Digital chloridometer, Buckler Instruments, Fort Lee, NJ. All 
electrolyte samples were assayed by the Clinical Pathology 
Laboratory, Oklahoma State University Veterinary Teaching Hos-
pital. Red blood cell counts were made with a UnopetteR system; 
hematocrit with microhematocrit methods; hemoglobin concentra-
tion with a Spencer hemoglobinometer; total protein with a re-
fractometer. 
Chemical procedures for dye determination are in the appen-
dix. Samples were analyzed with a Beckman DU-8 spectrophotome-
ter. 
Statistical Analysis 
The experimental design was an incomplete block design. 
The block design is an experimental plan where the block may be 
an individual or group of individuals that share some character-
istic which may influence the response to the treatment. In a 
complete block design, all treatments are associated with each 
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block. However, in the incomplete block.design not all treat-
·ments are associated with each block. In this study, the blocks 
were the individual dogs and two treatments were randomly as-
signed to each dog {Figure 4). This design was also set up to 
be a balanced design. The design was balanced with respect to 
the fact that 1) each treatment was assigned four dogs, and 2) 
each treatment appeared twice per trial {see Figure 4). The ori-
ginal design called for 2 trials per dog which would yield 20 
total trials. However, technical problems resulted in the loss 
of data from 3 trials, leaving an unbalanced design. 
The design used in this study also contained elements of a 
split unit design. In a split unit design, the investigator is 
usually interested in at least two factors, one factor contained 
within the other {i.e., nested design). The feature of this de-
sign is that there is a main unit or factor which is randomized 
within the block and there is a subunit which is randomized with-
in the main unit. In this study, the main unit is each dog dur-
ing a trial and the subunits are the time intervals when each ob-
servation was made within each trial. The main unit measures 
the effect of a treatment on a dog during a trial. The subunit 
measures the effect of time on each treatment within each trial. 
In this design, the accuracy of the evaluation on the main 
unit {treatment effect) is usually less than that of the subunit 
{time effect) for two reasons: 1) the error term of the main 
unit is associated with fewer degrees of freedom, therefore, the 
F statistic needed to demonstrate significant effect needs to be 
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TREATMENT: 1 2 3 4 5 
Dog # 
1 * * 
2 * * 
3 * *' 
4 * * 
5 * * 
6 * * 
7 * *' 
8 * * 
9 *' * 
10 * * 
Fi·gure 4. Experimental Design 
* Indicates treatment each dog received. 
I Indicates missing values for that treatment 
large; and 2) the main unit effect is averaged over time, so any 
variability over time is included in the error term for treatment 
effect (main unit error). It should be noted that, due to the 
above reasons, a nonsignificant result may indicate the experi-
ment was not preci·se enough to detect any differences. On the 
other hand, a significant result would be strong evidence in fa-
vor of that effect. 
The data was analyzed two times by analysis of variance pro-
cedures using the General Linear Models (GLM) program of the 
Statistical Analysis System (SAS) on the Oklahoma State University 
IBM 360 computer. The first analysis divided the data into four 
categories: 1) treatment effect; 2) dog effect; 3) time effect, 
and 4) time x treatment interaction. 
The effect of treatment was averaged over time, beginning 
with time O or the sample immediately following cessation of the 
thirty minute treatment period. The test for dog effect measured 
the variability between dogs against the variability within dogs 
(main unit error term). The variability within dogs is calculated 
as the variability between trials for each dog. The effect of 
time and time x treatment interaction were then measured. If a 
significant result appeared for the time x treatment interaction, 
this was taken to mean the magnitude of the response to one treat-
ment was not parallel to that seen in other treatments over time. 
If the test for the variability between dogs was not signifi-
cant (p>.05), the degrees of freedom and sum of squares for dogs 
were pooled with the main unit error, thus increasing the 
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ability to detect treatment differences.· It also simplified the 
calculation of standard errors to be used in comparing treatment 
differences in this unbalanced design. Thus, the second analy-
sis utilized the pooled sum of squares for the main unit error 
and the treatment effect was tested using this new term. The 
time and time x treatment interaction were not affected and thus 
the result from the second analysis of variance was the same as 
from the first analysis. Table IV gives examples of the two 
analysis of variance tables and the associated degrees of free-
dom. 
In this study, for all the variables studied, there was no 
significant difference between dogs. Therefore, all results re-
ported are from the second analysis. However, the results of 
the second analysis were similar to those of the first analysis 
with respect to treatment effect, time effect and time x treat-
ment interaction. 
If the treatment effect was significant ( p<.05) comparisons 
of groups of treatments and individuals were made. Referring to 
Table III (list of treatments) the comparisons of treatments were 
as follows: 
treatment(s) vs. 
4 
4,5 
1 
2 
4 
4 
4 
5 
5 
5 
treatment(s) 
5 
1 ,2 ,3 
2,3 
3 
l 
2 
3 
l 
2 
3 
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TABLE IV 
SAMPLE ANALYSIS OF VARIANCE TABLES 
a. Table used for detennination of differences between dogs 
Source Degrees of Freedom 
Treatment Effect 4 
Dog Effect 9 
Main Unit Error 3 
Time Effect 7 
Time x Treatment 
Interaction 28 
Sub Unit Error 79 
b. Table used with the pooled data: 
Source Degrees of Freedom 
Treatment Effect 4 
Main Unit Error 12 
Time Effect 7 
Time x Treatment 
Interaction 28 
Subunit Error 79 
The first comparison was a test for.the difference between 
the two bicarbonate solutions; the second was a test comparing 
the bicarbonate solutions against the lactate solutions and the 
control; the third was a test of the difference of the control 
against the lactate solutions and the fourth was a test of the 
difference between the two lactate solutions. The remainder of 
the comparisons were individual tests of the bicarbonate solu-
tions (treatments 4 or 5) against the remaining treatments (1, 2, 
or 3). 
Standard errors were calculated in the following manner: 
variance of main variance of subunit 
Std error= + 
unit error error 
N 
where N is the number of observations for that particular time 
and treatment. 
The changes in body fluid distribution were analyzed with a 
paired t-test, comparing the values obtained two days prior to 
the experiment with the values obtained immediately following 
treatment. 
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CHAPTER IV 
RESULTS 
Results of this study will be presented using the treatment 
numbers. For a description for each treatment, refer to Table 
III. 
Base Excess 
Table V and Figure 5 show the mean changes in base excess 
(± standard errors) for each treatment. In terms of correcting 
the acidosis, based on changes in base excess, it can be seen in 
Figure 5 that the group receiving the standard bicarbonate solu-
tion plus the dose correction for the base excess (treatment 5) 
showed the best response. Starting at the base excess of -4mEq/l, 
immediately after treatment, the base excess went to +0. 16, then 
remained well within the normal range for the rest of the obser-
vation period. Treatment number 4 (the standard bicarbonate so-
lution) also proved effective in correcting the base excess. 
This is in contrast to the lactate solutions (treatments 2 and 3) 
both of which did not change the base excess significantly from 
the initial pretreatment level of -4.0. This pattern follows the 
results from the comparison tests which showed: 1) treatments 
4 and 5 were significantly different from treatments l, 2, and 3 
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TABLE V 
BASE EXCESS. VALUES FOR ALL TREATMENT GROUPS (ITITiol/1) 
.. 
-· --- . -·--
:vr f,!-.~Ui: T 111E (MINUTES) N MEAN STANDARD 
POST TREATMENT ERROR 
. - -·· - . -
. - -----·-·------
Con l rtd 0 3 -4.4 .578 
nc flufd n•pl,,ct"mr.nl 10 3 -3.9 .578 
20 3 -2.5 .578 
30 3 -4.2 .578 
90 3 -4. l .578 
150 3 -4.6 .578 
210 3 -4.7 .578 
1-140 3 -3.3 .578 
z 100 m[q/1 Pld(I 0 4 -4.7 . 501 
25 n,r q/1 sodium ldctate 10 4 -4.3 .501 
25 m[ q/1 sodium gluconate 20 4 -5.1 .501 
30 4 -4.4 .501 
90 4 -4.4 .501 
150 4 -3.9 .501 
210 4 -4.5 .501 
1440 4 -4.4 .501 
3 100 m[q/1 NaCl_ 0 4 -3.1 .501 
25 mf'l.'1 S!lclium lactate • 10 4 -3.9 · .501 
Base [xress correction 20 4 -4.2 .501 
25 nt[q/ l sodium gluconate - 30 4 -4.6 .501 
Base Excess correction 90 J -3.9 .578 
150 4 -3.9 .578 
210 4 -4.3 .501 
1440 4 -4.1 .SOI 
4 100 m[q/1 NaCl 0 3 -3.1 .578 
ZS m[q/ l llaHCOJ 10 3 -3. I .578 
?5 mfo/l sodium 9lucondte 20 3 -2.4 .578 
30 3 -2.7 .578 
90 2 -2.3 .708 
150 2 -1. 7 • 708 
210 2 -2.2 • 708 
1440 3 -2.8 .578 
100 m[q/1 NaCl 0 3 0.16 .578 
25 mEq/1 NaHC03 + Base Excess 10 3 -1.0 .578 
correct ion 20 3 -1.5 .578 
?5 m[q/ I sodium 9luconate - 30 3 -1.4 .578 
Base Excess correction 90 3 
-1.0 .578 
ISO 3 -1. 3 .578 
210 3 -1.5 .578 
1440 J -0.9 .578 
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Figure 5. Mean Changes in Base Excess 
vs. Time For Each Treatment 
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when compared as a group (e.g., 4, 5 vs. 1, 2, 3) or when com-
pared individually (e.g., 4 vs. 1); 2) neither treatment 2 nor 
3 were significantly different from the control (treatment 1); 
and 3) treatment 4 was significantly different from treatment 5. 
Bicarbonate Concentration 
Table VI and Figure 6 show the mean changes in bicarbonate 
concentration(± standard errors). Referring to the graphs of 
the changes in bicarbonate concentration, it can be seen that, 
for all treatment groups, the values were below normal and were 
close to 30 mEq/1 for treatments 4 and 5, and approximately 
17-18 mEq/1 for treatments 1, 2 and 3. The comparisons between 
treatment groups showed a similar pattern to that for the varia-
ble base excess: treatments 4 and 5 (bicarbonate treatments) 
were significantly different from the control (treatment 1) and 
treatments 2 and 3 (lactate treatments); and treatments 2 and 3 
were not significantly different from the contrcil. There was, 
however, no difference between treatments 4 and 5. 
Table VII and Figure 7 show the mean changes in PC02. It 
can be seen that, for all treatment groups, the values were be-
low normal. Comparisons between treatment groups showed: sig-
nificant differences between the bicarbonate solutions and the 
other treatment groups; and no significant differences between 
the lactate groups and the control. 
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TABLE VI 
BICARBONATE CONCENTRATION {mEq/1) 
TREATMENT TIHE(HINUTES) N HEAN STANDARD 
POST TR£ATHENT ERROR 
Control - 0 3 17. l .77 
no fluid replacement 10 3 18.0 .77 
20 3 19.6 . 77 
30 3 17.3 ,77 
90 3 17'.9 . 77 
150 3 16.9 . 77 
210 J 17.0 . 77 
1440 3 18.9 .77 
2 100 mEq/1 sodium chloride 0 4 17 :5 .67 
25 mEq/1 sodium lactate 10 4 18. l .67 
25 mEq/1 sodium 9luconate 20 4 17 .0 .67 
JO 4 18.0 .67 
90 4 18.0 .67 
150 4 19. l .67 
210 4 17.8 .67 
1440 4 17.8 .67 
J 100 M6q/1 sodium chloride 0 4 19.2 ~ 
25 mEq/1 sodium lactate+ 10 4 18.3 .67 
Base Excess correction 20 4 17.5 .67 
25 mEq/1 sodium gluconate - 30 4 17.l .67 
Base Excess correction 90 3 17.8 .77 
150 4 18.3 .67 
210 4 17.8 .67 
1440 4 18.0 .67 
4 100 niEq/1 sodium chloride 0 3 19.3 . 77 
25 mEq/1 sodium bicarbonate 10 3 20.6 • 77 
25 m[q/1 sodium gluconate 20 3 19. 7 . 77 
30 2 20.2 .94 
90 2 20.9 .94 
150 2 21.4 .94 
210 2 20. 7 .94 
1440 3 19. 3 . 77 
5 100 mEq/1 sodium chloride 0 3 22.6 .77 
25 mEq/1 sodium bicarbonate+ 10 3 21. 7 . 77 
Sase Excess correction 20 20.9 . 77 
25 m[q/1 sodi~n gluconate 30 21.2 .17 
-Base Excess correction 90 3 21.8 .17 
150 3 21. 3 .17 
210 21.0 . 77 
1440 21.4 .17 
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TABLE VII 
PC02 VALUES FOR ALL TREATMENT GROUPS (mm Hg) 
I 
TREATMENT TIME(MINUTES) N MEAN STANDARD 
POST TREATMENT ERROR 
Control 0 3 26.2 1.64 
no fluid replacement 10 3 28.0 1.64 
20 3 29.4 1.64 
30 3 26.4 1.64 
90 3 27.2 1.64 
150 3 25. l 1.64 
210 3 26.0 1.64 
1440 3 29.0 1.64 
2 100 mEq/1 Na Cl 0 4 29.l 1.42 
25 mEq/1 sodium lactate 10 4 28.5 l._42 
25 mEq/1 sodium gluconate 20 4 28.0 l.42 
30 4 29.4 1.42 
90 4 30.0 1.42 
150 4 31. 7 1.42 
210 4 29.2 1.42 
1440 4 28.7 1.42 
3 100 mEq/1 NaCl 0 4 28.7 l.42 
25 mEq/1 sodium lectate + 10 4 29.2 1.42 
Base Excess correction 20 4 26.9 l.42 
25 mEq/1 sodium gluconate - 30 4 25.9 1.42 
Base Excess correction 90 3 27.2 1.64 
150 4 28.2 l.42 
210 4 27 .8 l.42 
1440 4 27.6 l.42 
4 100 mEq/ 1 NaCl 0 3 29.4 1.64 
25 mEq/1 NaHC03 10 3 32 .0 l.64 
25 mEq/1 sodium gluconate 20 3 31. 5 1.64 
30 2 32.0 2.01 
90 2 33.6 2.01 
150 2 34. 2 2.01 
210 2 32.3 2.01 
1440 3 29.3 1.64 
5 100 mEq/1 tlaCl 0 33.0 1.64 
25 mEq/1 NaHC03 + Base Excess 10 33.1 l.64 
correctfon 20 3 31.6 1.64 
25 mEq/1 sodium gluconatr. - 30 3 32 .1 1.64 
Base Excess correction 90 3 32.5 l.64 
150 3 32.6 1.64 
210 3 32.J I. 64 
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Changes in PC02 
Anion Gap 
Referring to the table of means (Table VIII), it can be seen 
that, although all treatment groups showed greater than normal 
anion gaps, the groups receiving the bicarbonate solutions 
(treatments 4 and 5} showed smaller anion gaps than the other 
groups. There was no significant difference between any of the 
treatment groups (p>.05}. 
Packed Cell Volume 
Referring to Table IX, it can be seen that the packed cell 
volume (PCV) decreased over time and showed similar changes in 
treatment groups 1-4. This would account for a significant time 
effect (p<.05), whereas there was not a statistically significant 
treatment difference. 
+ Na , Cl-, K+ 
Tables X, XI, and XII show the mean values {in mEq/1} for 
these ions. It can be seen that the values for sodium and chlo-
ride were relatively constant over time, while there was a slight 
increase in potassium concentration in all treatment groups. Se-
rum chloride values were slightly higher than normal for treat-
ment groups 1 and 4. There was no significant difference, how-
ever, between treatments and control of these variables. 
pH 
There was no significant treatment or time effect for this 
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TABLE VIII 
ANION GAP VALUES FOR ALL TREATMENT GROUPS (mEq/1) 
TREATMENT TIME(MJNUTES) N MEAN STANDARD 
POST TREATMENT ERROR 
I Control - D 3 20.93 3.72 
no fluid replacement ID 3 28.13 3.72 
20 3 24.26 3.72 
30 3 27.16 3.72 
90 3 27.23 3.72 
150 3 27.96 3.72 
210 3 30.83 3.72 
1440 3 25.3 3.72 
2 100 mEq/1 NaCl 0 4 28.9 3.22 
25 mEq/1 sodium lactate JO 4 26.1 3.22 
25 mEq/1 sodium gluconate 20 4 26.9 3.22 
30 4 30.5 3.22 
90 4 28.5 3.22 
150 4 27.8 3.22 
210 4 28.8 3.22 
1440 4 
-- 29.0 _ . 3.22 
3 100 mEq/1 NaCl 0 4 30.5 3.22 
25 mEq/1 sodium lactate+ 10 4 31.2 3.~2 
Base Excess correction 20 4 28.5 3.22 
25 mEq/1 sodium gluconate - 30 4 30.6 3.22 
Base Excess correction 90 3 31.6 3.72 
150 4 31.0 3.22 
210 4 30.4 3.22 
1440 4 29.8 3.22 
4 100 mEq/1 NaCl 0 3 21.3 3. 72 
25 mEq/1 NaHC03 10 3 22.8 3.72 
25 mEq/1 sodium gluconate 20 3 20.5 3.72 
30 2 22.4 4.56 
90 ·2 20.9 4.56 
150 2 23.85 4.56 
210 2 28.4 4.56 
1440 3 22.1 3. 72 
5 100 mEq/1 NaCl 0 3 26.2 3. 72 
25 mEq/1 NaHC03 + Base Excess 10 3 21.9 3.72 
correction 20 3 24.0 3. 72 
25 mEq/1 sodium gluconate - 30 3 22.1 3. 72 
Base Excess correction 90 3 24.0 J. 72 
150 3 24.6 3. 72 
210 3 28.5 3. 72 
1440 3 25.9 3. 72 
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TABLE IX 
PACKED CELL VOLUME 
TREATMENT Tl ME (MI NUTE S) N MEAN STANDARD 
POST TREATMENT ERROR 
Contro 1 - 0 3 38.3 2.56 
no fluid replacement 10 3 35.3 2.56 
20 3 35.0 2.56 
30 3 35.0 2 .56 
90 3 33.6 2.56 
150 3 34.0 2.56 
210 3 34.0 2.56 
1440 3 34.0 2.56 
2 100 meq/l NaCl 0 4 34. 7 1.42 
25 mEq/1 sodium lactate 10 4 33.6 1.42 
25 mEq/l sodium gluconate 20 4 33.7 l.42 
30 4 33.7 l.42 
90 4 33.2 l.42 
150 4 32. 7 I.42 
210 4 32. 7 1.42 
1440 4 33.5 1.42 
3 100 IIIEqLLHa.c I 0 4 34. 7 1.42 
25 111Eq/1° sodium lactate + 10 4 34.5 1.42 
Base Excess correction 20 4 34.0 1.42 
25 mEq/1 sodium gluconate - 30 4 33.7 1.42 
Base Excess correction 90 3 32.6 2 .56 
150 4 33.7 1.42 
210 4 33.0 1.42 
1440 4 32.0 1.42 
4 100 mEq/l NaCl 0 3 32.3 2.56 
25 mEq/1 NaHC03 10 3 31.6 2.56 
25 mEq/1 sodium gl ucona te ,'O 3 30.3 2 .56 
30 2 32.5 2.56 
90 2 33.0 3.13 
150 2 31. 5 3. 13 
210 2 31. 5 3. 13 
1440 3 29.3 2.56 
JOO mEq/1 tlaCl 0 3 32.6 2.56 
25 mEq/1 NaHC03 + Base Excess 10 3 32.6 2.56 
correct ion 20 3 32 .3 2.56 
25 mEq/l sodium 9luconate - 30 3 33.0 2.56 
Base Excess correction 90 3 32.0 2.56 
150 3 33.3 2. 56 
210 3 32.6 2.56 
1440 32. 3 2.56 
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TABLE x 
SERUM SODIUM CONCENTRATIONS (mEq/1) 
TREATHENT TiMt(MtAOTts) N MEAN STANDARD 
POST TIIEATMENT ERROR 
1 Control - 0 3 148.6 1.73 
no fluid replacement 10 3 151.6 1.73 
20 3 150.3 1.73 
JO 3 152.3 1.73 
90 3 151.6 1. 73 
150 3 151.0 1.73 
210 3 153.3 1.73 
1440 3 151.3 1.73 
2 100 mEq/1 NaCl 0 4 148.5 1.50 
25 mEq/1 sodium lactate 10 4 149.2 1.50-
25 mEq/1 sodi11111 gluconate 20 4 148.0 I.SO 
30 4 149.7 1.50 
90 4 147.2 1.50 
150 4 147.7 I.SO 
. ·-
210 4 147.5 I.SO 
1440 4 148.0 1.50 
3 100 inEq/1 NaCl 0 4 .148.0 1~50 
25 mEq/1 sodium lactate 10 4 149.0 1.50 
+ Base Excess correction 20 4 148.0 1.50 
25 mEq/1 sodium gluconate 30 4 147 .5 1.50 
- Base Excess correction 90 3 146.0 1. 73 
150 4 145.7 I.SO 
210 4 146.7 1.50 
1440 4 146.2 1.50 
4 100 mEq/1 NaCl 0 3 152.6 l.73 
25 mEq/1 NaHC03 10 3 152. 3 1. 73 
25 mEq/1 sodium gluconate 20 3 151.6 1.73 
30 2 151.5 I. 73 
90 2 152_0 2.12 
150 2 153.0 2 .12 
210 2 153.5 2 .12 
1440 152.0 l. 73 
5 100 mEq/1 NaCl 0 3 150.0 I. 73 
25 mEq/1 NaHC03 + Base 10 3 )48.6 I. 73 
Excess Correction 20 3 150.6 I. 73 
25 mEq/1 sodium gluconate 30 3 152.6 l. 73 
- Base Excess correction 90 3 151.0 1.73 
150 3 151 .6 ). 73 
,,,. 
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TABLE XI 
SERUM CHLORIDE CONCENTRATIONS {mEq/1) 
TREATMENT TIME (MINUTES) N HEAN STANDARD 
POST TREATMENT ERROR 
Control - 0 J 114.6 J.40 
no fluid replacement 10 J 109.6 J.40 
20 3 110.6 3.40 
JO 3 112.0 3.40 
90 J 110.6 3.40 
150 J 110. J J.40 
210 3 109.6 3.40 
1440 J 111.3 3.40 
2 100 mEq/1 NaCl 0 4 106.0 2.95 
25 mEq/1 sodium lactate 10 4 109.0 2.95 
25 mEq/1 sodium glu- 20 4 107 .5 2.95 
conate 30 4 105.2 2.95 
90 4 104. 7 2.95 
150 4 104. 7 2.95 
210 4 105.0 2.95 
1440 4 105.2 2.95 
J 100 mEq/1 Na Cl 0 4 102.0 2.95 
25 mEq/1 sodium lactate 10 4 103.2 2.95 
+Base-Excess correction 20 4 106.0 2.95 
ZS mEq/1 sodium 30 4 103.7 2.95 
g l ucona te - Base 90 3 101. 3 3.40 
Excess correction 150 4 100.5 2.95 
210 4 102.5 2.95 
1440 4 102. 7 2.95 
4 100 m(q/1 NaCl 0 116.0 3.40 
25 mEq/1 Na HC03 10 J 113.0 3.40 
25 rn(q/ I sodium 20 3 115.6 3.40 
gluconate 30 2 113.0 4. 17 
90 2 114. 5 4. 17 
150 2 112 .0 4 .17 
210 2 108.5 4. 17 
1440 3 114 .6. 3.40 
5 100 m£q/l Nae I 0 3 105.3 3.40 
25 mEq/1 NaHCOJ • 10 J 109.0 3.40 
Base Excess correction 20 3 109.6 3.40 
25 mlq/1 sodium glu- 30 3 113.3 3.40 
conate - Base Excess 90 3 109. 3 3.40 
correct ion ISO 3 109.6 3.40 
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TABLE XII 
SERUM POTASSIUM CONCENTRATIONS (mEq/1) 
TREATMENT TIHE(HINUTES) N HEAN STANDARD 
POST TREATMENT ERROR 
Control - 0 3 4.13 .232 
no fluid rep l acenent JO 3 4.20 .232 
20 3 4.23 .232 
30 3 4.20 .232 
90 3 4. 13 .232 
150 3 4.23 .232 
210 4.23 .232 
1440 3 4 .20 .232 
2 100 mEq/1 NaCl 0 4 4.02 .201 
25 mEq/l sodium lactate 10 4 4.00 .201 
25 m[q/ l sodium gluconate 20 4 4.05 .201 
30 4 4.07 .201 
90 4 4.05 .201 
150 4 4.05 .201 
210 4 4.20 .201 
1440 4 4.15 .201 
3 100 mEq/ l NaCl 0 4 3. 77 .201 
25 mEq/1 sodium lactate 10 4 3.87 .201 
+ Base Excess correction 20 4 4.07 .201 
25 m[q/1 sodium gluconate 30 4 4.02 .201 
- Base Excess correction 90 3 4.26 .232 
150 4 4.10 .201 
210 4 4.07 . 201 
1440 4 4. 32 .201 
100 mEq/ l NaCl 0 J 4.00 .232 
25 mfq/1 NallC03 10 4. 13 .232 
25 m(q/1 sodium ~l uconate 20 4.20 .232 
30 2 4.20 .284 
90 2 4. 35 .284 
150 2 4.25 .284 
l!O 2 4. 15 .284 
1440 4. IO . 232 
5 100 m[q/1 llaCl 0 4.23 .232 
25 m(q/ 1 lldtlC03 • Rdse IO 3 3. 93 .232 
Excess correction 20 3 4.00 .232 
25 m(q/1 sodium yluconatc 30 4.06 . 232 
- Base [xcess cnrrrction 90 4 .13 . 232 
150 4.00 . 232 
710 
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variable and all values were within normal limits. 
Dye Determinations 
There was no significant difference in the pre-treatment 
and post-treatment values_ for any of the body fluid spaces for 
treatments 2-5 (Table XIII}. There was a significant difference 
in the pre-treatment/post-treatment values for blood volume in 
the control group (treatment l}. The values indicate a reduc-
tion in blood volume of approximately 17% following hemorrhage. 
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TABLE XIII 
TABLE OF MEAN± STANDARD ERRORS FOR CHANGES IN FLUID COMPARTMENTS, 
PRECEDING AND AFTER TREATMENT (VALUES IN LITERS) 
PRETREATMENT POST TREATMENT 
Blood 
Volume TRT# 
1 1. 37, . 219 1.14, .19* 
2 1. 35, . lll 1. 39, .181 
3 1.11, .164 1.06, .14 
4 1.00, .409 .98, .37 
5 .94, .233 .933, . 218 
ECF 1 3.67, .58 3.39, .563 
2 3.7, . 34 3.79, . 36 
3 3. 02, .50 3.06, . 49 
4 2.61, 1. 0 2.61, .98 
5 2.4, . 572 2.4, .53 
ISF 1 2.7, .44 2.6, .43 
2 2.8, .28 2.84, .26 
3 1. 9' . 372 2.3, .4 
4 1. 9' .78 1. 9' .73 
5 1. 8, .42 1. 78, . 39 
TBW 1 11. 18, 1. 6 10. 9, 1.6 
2 11. 6, 1. 2 11. 7, 1.1 
3 8.7, 1. 5 8.7, 1. 3 
4 7.8, 3.0 7.8, 3.0 
5 7.6~ 1.6 7.5, 1.6 
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CHAPTER V 
DISCUSSION 
The changes that occur in the cardiovascular system follow-
ing the loss of blood, are designed to maintain the blood pres-
sure. Through the release of norepinephrine and epinephrine, 
vasoconstriction occurs, along with an increase in blood pres-
sure. Vasoconstriction leads to a decreased perfusion of cer-
tain tissues, to supply blood to vital organs. The shift of 
blood is usually away from organs such as the gastrointestinal 
tract, to maintain perfusion to the heart, lungs and brain. 
This decrease in perfusion to the GI tract will lead to an in-
creased dependence on local anaerobic metabolism. 
The changes in cellular metabolism during anaerobiosis in-
clude an increased dependence on glycolysis for energy. 50 This 
is due to inhibition of the high energy yielding reactions of the 
tricarboxylic acid cycle. The result is an increase in the local 
concentrations of hydrogen ions, adenosine, lactic acid and other 
organic acids and carbon dioxide. 
Diagnosis of Metabolic Acidosis 
The changes that occur in the pH, the bicarbonate buffer 
system and PC02 can be monitored with blood gas analysis. In the 
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case of a simple metabolic acidosis (i.e., no other acid base 
disturbance is present) a diagnosis can be established by the 
presence of a low plasma bicarbonate, low blood pH and reduced 
PC02. 
The decrease in plasma sodium bicarbonate is a result of 
titration with the organic acids. The subsequent decrease in pH 
and further increase in hydrogen ion (or organic acid) concentra-
tion will lead to stimulation of respiratory ventilation. The 
increased ventilation in response to a decrease in pH will lead 
to a decrease in PC02 in an attempt to restore pH. Depending on 
the relative magnitude of the changes in PC02 and sodium bicarbo-
nate concentration, the pH will change accordingly. 
An index used in estimating the severity of acid base dis-
turbances is the base excess. The base excess is the deviation 
in bicarbonate concentration from the normal value of 24 mEq/1. 
It is calculated from the bicarbonate concentration, hemoglobin 
and pH. It is a reflection of the titration of blood and thus 
more accurate than just the bicarbonate concentration or pH in 
describing changes in the bicarbonate buffer system. Acidosis is 
associated with a negative base excess; alkalosis is associated 
with a positive excess. 
In this study, a base excess of~ -4 mmol/1 was the crite-
rion for metabolic acidosis and treatment. The results from the 
control group indicate that removal of 20% of the measured blood 
volume of conscious dogs is sufficient to lower the pH and in-
crease the base excess. It can also be seen that, even after 24 
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hours, the animals are still acidotic by the criteria of the ex-
periment. The sodium bicarbonate concentrations remain low, as 
well, throughout the experiment. The changes in PC02 seen in 
this group were also expected, and are probably a result of the 
respiratory compensation for metabolic acidosis. Although the 
respiratory rates were not measured in all dogs, respiration 
rate and depth were noted for animals of the control group fol-
lowing hemorrhage. In these animals, rate and depth increased 
following hemorrhage. 
Another measure of the severity of metabolic acidosis is 
the anion gap. Data from the control group indicate the presence 
of a clinical acidosis (anion gap> 20 mEq/1), and this was ob-
served through all measured intervals. The increase in the anion 
gap is a result of an increase in organic acid anions (i.e., 
lactic) which are known to increase as a result of tissue hypoxia 
produced by vasoconstriction following blood loss. Although the 
actual composition of the increase in unmeasured anions was not 
determined, Huckabee showed that a loss of blood will produce 
an increase in the concentration of lactic acid. This increase 
is seen even when blood loss is not sufficient to produce noti-
ceable changes in blood pressure. 
The importance of changes in the above indices (PC02, anion 
gap, bicarbonate concentration and base excess) is best seen in 
those groups receiving fluid replacement. In this study, two 
levels of base concentration were used. The lower level repre-
sented a standard or maintenance dose. The intention was to add 
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a concentration of base that, when infused, would not result in a 
dilutional acidosis and this dose was 25 mEq/1. The objective 
of the higher dose was to add base in a contration to correct 
for the observed base excess. The two bases utilized were so-
dium lactate and sodium bicarbonate in a solution containing so-
dium chloride and sodium gluconate.* 
Dilutional Acidosis 
The data from the two groups receiving the low dose of base 
seem to indicate that, while the sodium bicarbonate solution re-
stored the base excess to within normal limits (0 ± 3 mmol/1), 
there was still some apparent dilution of the bicarbonate buffer 
system. However, this may be due to the fact that there was not 
enough base present in the infusion solution to correct for the 
sodium bicarbonate already depleted. This will be discussed in 
more detail below. 
The group receiving the lower dose of sodium lactate did 
not respond any differently than the control. There are a few 
possibilities for this result. First, although sodium lactate 
can act as a base and accept hydrogen ions at pH values near its 
pKa (3.9), at a pH of 7.4 the ionization constant favors the 
formation of sodium lactate and not lactic acid. At a pH of 7.4, 
99% of the lactate present exists as the sodium salt. 
Second, if the organic acid acidosis was attributable to an 
increase in lactic acid, any titration reaction would be: 
*NOTE: It has been shown that sodium gluconate has no observable 
effect on any of the indices measured. 
66 
sodium lactate+ lactic acid lactic acid+ sodium lactate 
In other words, there would be no net decrease in the concentra-
tion of lactic acid. 
Another factor in the lack of response of the low dose lac-
tate group is that the metabolic pathways of lactate utilization 
are inhibited during acidosis. The rationale behind the use of 
lactate as an alkalinizing agent is that lactate is metabolized 
into bicarbonate. However, the oxidation of lactate will only 
produce co2 and H20 via the TCA cycle. If this carbon dioxide 
and water would combine to form carbonic acid, which would then 
dissociate into hydrogen and bicarbonate ions, the bicarbonate 
ion could combine with the sodium ion frem the sodium lactate. 
The hydrogen ion would then have to be buffered, and it would ap-
pear to defeat the purpose of adding the base to correct the 
acidosis. Another problem with this idea is the fate of the 
sodium ion from the infused sodium lactate. Once the lactate 
ion is released, the sodium ion would either have to be elimi-
nated (via the kidney) or it would have to com.bine with another 
anion, such as intracellular chloride or bicarbonate. This gives 
yet another possible explanation for the rise in bicarbonate 
observed in this study at 90-150 minutes and in other investiga-
tions: ion exchange. This ion exchange would be extracellular 
lactate for intracellular bicarbonate or chloride. This might 
account for the higher than normal values obtained for serum 
chloride concentration. The magnitude of the change in plasma 
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sodium bicarbonate in the present study was not as great as that 
observed by Hartsfield et a1. 99 It should be noted, however, 
that, in the present study, the concentration of lactate used 
was much smaller (25 mEq/1 in a volume equal to 20% of the blood 
volume) than than in the Hartsfield study (6.6 mEq/kg). 
The use of the higher doses of these bases was intended to 
correct for the base excess. The group receiving the high dose 
of sodium lactate did not respond any differently than the con-
trol or low dose of lactate. The group of animals receiving the 
corrected dose of sodium bicarbonate had the best response, with 
respect to changes in the base excess. It should be noted that, 
even in this group, the bicarbonate values were still lower than 
normal. This might be explained by the fact that the correction 
factor, 0.3 x Body Wt (Kg), represents a change in the bicarbo-
nate concentration of only extracellular fluid. It has been 
shown that 50% of the buffering of acid occurs with intracellular 
buffers. Therefore, due to the dampening of changes of extracel-
lular bicarbonate by hemoglobin, the intracellular stores of 
NaHC03 are being depleted before any observable changes in extra-
cellular NaHC03 occur. This correction factor (0.3) thus under-
estimates the depletion of the bicarbonate buffer due to consump-
tion by organic acid. This is consistent with the observations 
of Garella et al,42 who have shown that the volume of distribu-
tion of sodium bicarbonate increases with the severity of the 
acidosis. 
The changes in the concentration of the electrolytes, sodium 
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and potassium, are consistent with changes that might be seen 
during organic acid acidosis. The changes in sodium are approxi-
mately 1% from time zero, which is a similar percentage to that 
obtained by Swan and Pitts. This corresponds to buffering by 
plasma proteins. The changes in plasma K+ are consistent with 
the entry of organic acids into the intracellular fluid. If the 
acid enters intracellular fluid as the anion, a positive intra-
cellular ion is necessary (i.e., potassium). If the organic 
acid entered as the intact molecule, displacement of an intra-
cellular cation would not be necessary. The slight increase in 
plasma potassium might be related to the observation that acute 
metabolic acidosis will lead to a decreased potassium excretion. 
Fluid Shifts 
The data from the fluid shift study and PCV data would seem 
to indicate that the infused solutions remained within the vas-
cular compartment, leading to a dilution of the remaining blood 
volume. This dilution corresponds to a decrease in packed cell 
volume seen for all groups. The decrease in the PCV in the con-
trol gro.up could be a result of a fluid shift - interstitial 
fluid to vascular compartment, and is consistent with known data. 
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CHAPTER VI 
SUMMARY AND CONCLUSIONS 
In conclusion, it appears that, for the correction of an 
acidosis produced by the removal of 20% of the measured blood 
volume of dogs, a solution containing a maintenance dose of so-
dium bicarbonate (24 mEq/1) plus a dose for the correction of the 
base excess (0.3 x body weight in kilograms) was the most effi-
cient when compared to solutions containing sodium lactate and 
the untreated control group. 
The index used to determine acidosis was the base excess and 
it was found that the groups receiving the bicarbonate solutions 
remained within the normal range of base excess for the observa-
tion period. The groups receiving the lactate solutions remained 
at the level of the untreated groups for the duration of the ex-
periment. Elevation of the anion gap was the greatest for these 
latter groups. The PC02 and bicarbonate concentrations were 
lowest for the lactate and untreated groups. However, the bicar-
bonate was below normal for the animals receiving the bicarbonate 
solutions, perhaps indicating a dilution of the plasma bicarbo-
nate by fluid administration. This would appear to indicate 
that the use of at least 25 mEq/1 sodium bicarbonate is necessary 
to prevent a more severe dilution of the plasma buffer systems 
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following the administration of intravenous fluids. It should 
be noted that, although the animals receiving the lactate solu-
tions responded in a similar manner as the untreated group, 
fluid replacement is still a priority in the treatment of hypo-
volemia. 
Changes in plasma sodium, chloride and potassium were con-
sistent with the changes that might occur in these parameters 
during an organic acid acidosis. 
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APPENDIXES 
81 
ANTIPYRINE ANALYSIS 
1. Unknown determination is made with plasma. 
2. Separate plasma. 
3. Add: 1 ml cadmium sulfate reagent 
1 ml 4. 4~~ NaOH 
to 2 ml plasma. Stir. then centrifuge. 
4. Label three tubes: BLANK STANDARD TEST 
5. The Standard tube contains: 0.2 mg antipyrine 
1.5 ml protein free 
filtrate 
The Text tube contains: 
6. Add: 5 ml glacial acetic acid 
0.25 ml of 15% sodium nitrite 
to all three tubes. 
7. Let stand for 20 minutes. 
8. To all tubes add: 
0.25 ml ammonium sulfamate 
Shake well. 
1 ml 10% 1-napthylamine solution in glacial 
acetic acid 
Heat@ 50°C for 5 minutes. 
Cool; let stand for 20 minutes. 
9. Read absorbance at 580 nm. 
82 
POTASSIUM THIOCYANATE ANALYSIS 
1. 1 ml of plasma+ 1 ml 10% Trichloroacetic acid 
2. Shake, then centrifuge. 
3. 1 ml of the supernatant+ 1 ml distilled water+ 
1 ml 5% Fe(N03)3 in HN03 
4. Read at 460 nm. 
5. Extracellular fluid space+ 0.7 x thiocyanate space 
83 
VITA 
Howard Jeffrey Mass 
Candidate for the Degree of 
Doctor of Philosophy 
Thesis: A STUDY OF THE TREATMENT OF METAPOLIC ACIDOSIS IN DOGS 
Major Field: Physiological Sciences 
Biographical: 
Personal Data: Born in Brooklyn, New York, April 18, 1954, the 
son of Gerald and Lillian Mass. 
Education: Graduated from Lenape High School in May, 1972; re-
ceived the Bachelor of Arts degree from University of 
Delaware in May, 1976, with a major in Biology; received 
the Master of Science degree at Oklahoma State University, 
July, 1980, with a major in Physiological Sciences; com-
pleted requirements for the Doctor of Philosophy degree 
with a major in Physiological Sciences at Oklahoma State 
University, May, 1984. 
Professional Experience: Science Associate, Department of 
Physiology, Texas College of Osteopathic Medicine, Septem-
ber, 1982 - present; teaching assistant, Department of 
Physiological Sciences, Oklahoma State University, Septem-
ber, 1977 to May, 1980; teaching Introductory Physiology 
Laboratory and Veterinary Physiology Laboratory; laboratory 
assistant in the Department of Physiological Sciences, 
Oklahoma State University, May, 1979 to August, 1979. . 
